Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Retrophin Inc (NASDAQ:RTRX)

27.76
Delayed Data
As of 3:28pm ET
 +0.31 / +1.13%
Today’s Change
7.85
Today|||52-Week Range
37.04
+126.80%
Year-to-Date
No recent news for Retrophin Inc.

Today’s Trading

Previous close27.45
Today’s open27.21
Day’s range27.21 - 28.31
Volume382,200
Average volume (3 months)526,624
Market cap$981.2M
Dividend yield--
Data as of 3:28pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)-86.13%
Earnings growth (this year)+128.23%
Earnings growth (next 5 years)+8.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales10.87
Price/Book--

Competitors

 Today’s
change
Today’s
% change
RLYPRelypsa Inc+0.56+2.36%
AIMTAimmune Therapeutics...-0.27-1.26%
CHRSCoherus BioSciences ...+0.18+0.63%
ATRAAtara Biotherapeutic...+0.10+0.25%
Data as of 3:43pm ET, 08/28/2015

Financials

Next reporting dateNovember 12, 2015
EPS forecast (this quarter)$0.12
Annual revenue (last year)$28.2M
Annual profit (last year)-$110.9M
Net profit margin-393.35%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Stephen J. Aselage
Chief Financial Officer &
Senior Vice President
Laura M. Clague
Corporate headquarters
San Diego, California

Forecasts

Partner Offers